Frontlight ResearchEarly access
TerminatedNo phase
The Efficacy & Safety of rTMS for Upper-limb Motor Function Recovery in Subcortical and Brainstem Stroke
Key facts
- Who runs it
- Seoul National University Bundang Hospital
- Where
- South Korea2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 60 people enrolled
- Started
- 2 Jan 2023
- Ended
- 31 Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Low-frequency rTMS (experimental)
- Low-frequency rTMS (sham comparator)
- Record updated
- 12 January 2026
- Why it stopped
- Due to difficulty in patient recruitment
Who can take part
- Age
- 19 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- 19-80 years old
- Radiologically confirmed ischemic stroke with subcortical and brainstem lesions within 90 days
- Fugl-Meyer assessment scale (upper extremity) > 15
- Mini-mental status exam (the Korean version) > 14 with appropriate cognitive function
- Written informed consent
Who cannot take part
- Previous history of stroke
- Previous history of brain surgery
- Intracranial metal implant
- Inability to receive regular physical or occupational therapy
- Hemorrhagic stroke or traumatic brain injury
- Cerebellar stroke
- Need for intensive care due to complications associated with stroke (e.g. pneumonia, infection, hemodynamic instability)
- History of psychological or neurological diseases
- History of pain or muscular weakness of upper limbs which may interfere with rehabilitation
- History of seizure or epilepsy
- Disagreement to use contraception in women of childbearing age
- Fugl-Meyer assessment scale (wrist) < 1 or Fugl-Meyer assessment scale (hand) < 1
- Traumatic brain injury
- Aphasia
- Skin lesions in the stimulation site of scalp
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of this study is to evaluate the efficacy and safety of repetitive transcranial magnetic stimulation applied with an electromagnetic therapy stimulator 'ALTMS-A' for upper-limb motor function recovery with the sham control group for those who need upper-limb rehabilitation treatment for subcortical and brainstem stroke
The 2 groups in the trial
- real rTMSTreatment being tested
Use the real rTMS coil
Treatment: Low-frequency rTMS (experimental)
- sham rTMSSham treatment, for comparison
Use the sham rTMS coil
Treatment: Low-frequency rTMS (sham comparator)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Multi-center, Prospective, Comparative, Randomized, Double Blind, Superior, Pivotal Study to Compare and Evaluate the Efficacy and Safety of Repetitive Transcranial Magnetic Stimulation Applied With an Electromagnetic Therapy Stimulator 'ALTMS-A' for Upper-limb Motor Function Recovery With the Sham Control Group for Those Who Need Upper-limb Rehabilitation Treatment for Subcortical and Brainstem Stroke (Ischemic)
- Publications
- Record updated
- 12 January 2026